Jan 23 (Reuters) - Diagnostic devices maker Alere Inc said U.S. health regulators cleared its rapid influenza test for use in the country. The U.S. Food and Drug Administration granted Alere Influenza ...
* Alere I testing applications have previously been clia-waived for Influenza a & b and strep a Source text for Eikon: Further company coverage: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results